Inflammasomes are critical for mounting host defense against pathogens. The molecular mechanisms that control activation of the AIM2 inflammasome in response to different cytosolic pathogens remain unclear. Here we found that the transcription factor IRF1 was required for activation of the AIM2 inflammasome during infection with the Francisella tularensis subspecies novicida (F. novicida), whereas engagement of the AIM2 inflammasome by mouse cytomegalovirus (MCMV) or transfected double-stranded DNA did not require IRF1. Infection of F. novicida detected by the DNA sensor cGAS and its adaptor STING induced type I interferon-dependent expression of IRF1, which drove the expression of guanylate-binding proteins (GBPs); this led to intracellular killing of bacteria and DNA release. Our results reveal a specific requirement for IRF1 and GBPs in the liberation of DNA for sensing by AIM2 depending on the pathogen encountered by the cell.
Inflammasomes are cytosolic multimeric protein complexes that provide host defense against microbial pathogens and have a role in the development of autoinflammatory and metabolic diseases 1 . Formation of the inflammasome is initiated by sensors of the innate immune system, including nucleotide-binding oligomerization domain (Nod)-like receptors (NLRs) or AIM2-like receptors (ALRs), following detection of microbe-associated or damage-associated molecular patterns in the cytoplasm of a cell 2 . In most cases, NLRs and ALRs engage the adaptor ASC, whose caspase-recruitment domain is critical for subsequent interaction with the caspase-recruitment domain of procaspase-1 (ref. 3) . Activation of caspase-1 induces proteolytic cleavage and release of mature interleukin 1β (IL-1β) and IL-18, as well as the induction of a type of pro-inflammatory cell death called 'pyroptosis' 2 . Therefore, inflammasomes are able to mount innate immunological effector functions in response to a range of stimuli encountered by the cell.
AIM2 is a member of the ALR family that contributes to the host defense against bacterial pathogens and viral pathogens, such as Francisella tularensis and cytomegalovirus, respectively [4] [5] [6] [7] [8] [9] . AIM2 contains a HIN-200 domain that directly binds double-stranded DNA (dsDNA) released into the cytosol of a cell during a microbial infection [4] [5] [6] [7] . Similarly, self DNA that is released into and accumulates in keratinocytes also activates the AIM2 inflammasome to drive the release of IL-1β in lesions of patients with psoriasis 10 , which indicates that AIM2 also responds to endogenous dsDNA released during cellular damage. Structural analysis has demonstrated that the positively charged HIN-200 domain of AIM2 embraces the dsDNA, whereas the pyrin domain of AIM2 facilitates the recruitment of ASC 11 .
The molecular mechanisms that govern assembly of the AIM2 inflammasome are less clear than those for the NLRP3 inflammasome. NLRP3 is activated by a plethora of microbe-associated and damage-associated molecular patterns. Activation of the NLRP3 inflammasome requires two signals 3 . The first signal, or 'priming' , is provided by the engagement of Toll-like receptors (TLRs), the receptor Nod2 or the receptor for tumor-necrosis factor to activate the transcription factor NF-κB and induce NLRP3 expression. The second signal is provided by an NLRP3 activator; these include ATP, uric acid crystals, silica, asbestos, bacterial messenger RNA, bacterial DNA-RNA hybrids and muramyldipeptide 3 . In addition, signaling via type I interferons is critical for activation of the so-called 'noncanonical' NLRP3 inflammasome 12, 13 . In this context, extracellular lipopolysaccharide (LPS) from Gram-negative bacteria activates TLR4 and its adaptor TRIF to induce the expression of type I interferons and pro-caspase-11 (refs. 12-15) . LPS released into the cytosol by means of vacuolar lysis binds caspase-11, which leads to caspase-11-dependent cell death and activation of the non-canonical NLRP3 inflammasome [16] [17] [18] [19] [20] . In contrast, AIM2 is constitutively expressed and does not require NF-κB-mediated priming for its activation 6 . Instead, signaling via type I interferons contributes to activation of the AIM2 inflammasome in response to certain pathogens, such as the F. tularensis subspecies novicida (F. novicida), but not in response to the DNA virus mouse cytomegalovirus (MCMV) 8, 21 . Therefore, the downstream mechanism that leads to activation of the AIM2 inflammasome in response to different pathogens is probably different and remains to be resolved 3 .
Here we identified two distinct pathways that led to activation of the AIM2 inflammasome. We found that engagement of the AIM2 inflammasome by infection with F. novicida required the transcription factor IRF1 but not TRIF or caspase-11. IRF1 was required for robust expression of small interferon-inducible GTPases known as 'guanylatebinding proteins' (GBPs), which killed cytosolic F. novicida and mediated the release of DNA for access by AIM2. In addition, IRF1-deficient (Irf1 −/− ) mice failed to control infection with F. novicida. In contrast, engagement of AIM2 via MCMV or transfected dsDNA did not require IRF1. Therefore, we have identified a specific requirement for IRF1 and GBPs in F. novicida-induced activation of the AIM2 inflammasome.
RESULTS
IRF1 mediates AIM2 activation by F. novicida F. tularensis, a pathogen that causes a rapid and lethal infections in humans and mice, is recognized by the AIM2 inflammasome 8, 9, 22 . In unprimed primary mouse bone marrow-derived macrophages (BMDMs), F. novicida induced AIM2-dependent activation of caspase-1, release of IL-1β and IL-18 and cell death in a manner that required type I interferon receptor 1 (IFNAR1) and IFNAR2 and components of the transcription factors ISGF3, STAT1 and IRF9 (refs. 8,9,21,22) (Fig. 1a and Supplementary Fig. 1a) . In contrast, activation of the AIM2 inflammasome by transfection of the dsDNA ligand poly(dA:dT) occurred independently of signaling via type I interferons (Fig. 1a) . The type I interferon signature that leads to activation of the AIM2 inflammasome in response to infection with F. novicida is unknown. The production of type I interferons induced by the TLR adaptor TRIF is required for robust activation of the caspase-11-NLRP3 inflammasome in macrophages infected with Citrobacter rodentium, Escherichia coli or Vibrio cholerae 12, 13, 15 ; however, we found that TRIF and caspase-11 were dispensable for activation of the AIM2 inflammasome by F. novicida (Fig. 1b) . Indeed, F. novicida synthesizes a tetra-acylated lipid A that differs to the hexa-acylated species of many enteric bacteria that normally activates caspase-11, which explains the ability of F. novicida to evade caspase-11-mediated detection 18 . These findings suggested that an as-yet-undefined type I interferon signature independent of TRIF and caspase-11 was needed to engage the AIM2 inflammasome by infection with F. novicida but not in response to transfected dsDNA.
We performed microarray analysis to identify genes regulated differentially in wild-type and IFNAR1-deficient (Ifnar1 −/− ) BMDMs that had been infected with F. novicida. The expression of many members of the IRF family of interferon-regulatory transcription factors, including IRF1, IRF7 and IRF9, was significantly reduced in the absence of IFNAR1 (Fig. 1c) . IRF9, a subunit of the ISGF3 complex, contributed to activation of AIM2 inflammasome by infection with F. novicida ( Fig. 1a and Supplementary Fig. 1a) , and we excluded the possibility of a role for IRF7 in activation of the AIM2 inflammasome upon infection with F. novicida (Supplementary Fig. 1b) . Confirmation of IRF1 protein expression indicated that it was robustly upregulated by infection with F. novicida through a mechanism that required IFNAR1, IFNAR2, STAT1 and IRF9 (Fig. 1d) . Consistent with that, BMDMs stimulated with recombinant mouse interferon-β (IFN-β) also robustly upregulated IRF1 expression, which was critically dependent on type I interferon receptors (Supplementary Fig. 1c) .
To investigate whether IRF1 is an upstream molecule that leads to activation of the AIM2 inflammasome, we infected unprimed wildtype and Irf1 −/− BMDMs with F. novicida and analyzed inflammasome responses 20 h later. Notably, unprimed Irf1 −/− BMDMs failed to respond to F. novicida-induced, AIM2-dependent activation of caspase-1, release of IL-1β and IL-18 and cell death, whereas their NS, not significant; *P < 0.05, **P < 0.01, ***P < 0.001 and ****P < 0.0001 (one-way analysis of variance (ANOVA) with Dunnett's multiple-comparisons test). Data are representative of two (b) or three (a,d) independent experiments (mean and s.e.m.) or one experiment with two biological replicates per genotype (c).
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A r t i c l e s wild-type counterparts exhibited robust AIM2 inflammasome responses ( Fig. 2a-d) . In contrast, Irf1 −/− BMDMs responded normally to the transfected dsDNA ligands poly(dA:dT) and plasmid pcDNA3.1 DNA and induced AIM2-dependent maturation of caspase-1, release of IL-18 and cell death (Fig. 2a-f) . Consistent with that, Irf1 −/− BMDMs had an impaired ability to generate an inflammasome speck in response to infection with F. novicida but not in response to transfected poly(dA:dT) ( Supplementary Fig. 1d,e) . Analysis of mRNA transcripts of Aim2 and Il1b by quantitative RT-PCR revealed similar expression of these genes in wild-type and Irf1 −/− BMDMs infected with F. novicida (Supplementary Fig. 2a) . The levels of the pro-inflammatory cytokines tumor-necrosis factor and IL-6 were slightly lower in Irf1 −/− BMDMs than in wild-type BMDMs (P > 0.05), whereas the level of the chemokine CXCL1 (KC) was similar in Irf1 −/− and wild-type BMDMs (Supplementary Fig. 2b) . Accordingly, the level of IL-12 was lower in F. novicida-infected Irf1 −/− BMDMs than in F. novicida-infected wild-type BMDMs (Supplementary Fig. 2c) .
We next investigated whether IRF1 was required for activation of the AIM2 inflammasome in response to MCMV 9 . Notably, engagement of the AIM2 inflammasome with MCMV did not require IRF1 (Fig. 2c,d,g,h) . This indicated that detection of bacteria and viruses by AIM2 occurred via distinct pathways governed by the requirement for IRF1.
IRF1 has been identified as a transactivator of IFN-β 23 , which suggests that defective production of IFN-β might lead to impaired activation of the AIM2 inflammasome. Although we detected reduced expression of the gene encoding IFN-β in Irf1 −/− BMDMs infected with F. novicida (Supplementary Fig. 2d ), priming of Irf1 −/− BMDMs with recombinant IFN-β failed to 'rescue' activation of the AIM2 inflammasome by F. novicida, whereas stimulation with IFN-β increased AIM2-dependent maturation of caspase-1 in wild-type cells in a dose-dependent way (Fig. 2i) . These findings suggested that the defective activation of the AIM2 inflammasome in Irf1 −/− BMDMs was not due solely to reduced production of IFN-β but largely reflected defects in additional IRF1-mediated processes.
IRF1 is dispensable for the NLRP3 and NLRC4 inflammasomes
To investigate whether IRF1 is required for activation of additional inflammasomes, we stimulated unprimed wild-type and Irf1 −/− BMDMs with activators of the canonical NLRP3 inflammasome (ATP and nigericin) and activators of the non-canonical NLRP3 inflammasome (C. rodentium and Salmonella enterica serovar Typhimurium (S. Typhimurium) lacking the flagellin subunits fliC and fljB) 17 . We found that Irf1 −/− BMDMs underwent normal activation of caspase-1, release of IL-1β and IL-18 and cell death in response to activators of the canonical or non-canonical NLRP3 inflammasome (Fig. 3a,b) . In addition, wild-type and Irf1 −/− BMDMs infected with S. Typhimurium grown to log phase, which activates the NLRC4 inflammasome via an SPI-1 type III secretion system 23 , showed similar levels of activation of caspase-1, release of IL-1β and IL-18 and cell death (Fig. 3c,d ), which indicated that IRF1 did not interfere with activation of the NLRC4 inflammasome. 
Casp-1 p20 (Fig. 4a) . Aim2 −/− BMDMs, in contrast, showed elevated expression of genes encoding GBPs and other interferon-inducible genes, relative to their expression in wild-type BMDMs (Fig. 4a,b) , an observation supported by the negative regulatory effect of AIM2 on interferon responses 8, 9 . We further confirmed by real-time quantitative RT-PCR analysis the downregulation of GBP-encoding genes in the absence of IRF1 or IFNAR1 (Fig. 4b) .
Activation of the AIM2 inflammasome requires GBPs
Genes encoding GBPs are located on mouse chromosomes 3 and 5 (ref. 24) . Those located on chromosome 3 (Gbp1, Gbp2, Gbp3, Gbp5 and Gbp7) encode GBPs linked to the control of bacterial and parasitic replication 19, 24 . To investigate the role of these GBPs in activation of the AIM2 inflammasome, we obtained BMDMs from mice lacking the GBP-encoding locus on chromosome 3 (called 'Gbp chr3 ' here) 19, 24 and infected the cells with F. novicida. We observed significantly decreased levels of activation of caspase-1, release of IL-1β and IL-18 and induction of cell death in F. novicidainfected BMDMs in which Gbp chr3 was deleted, relative to their levels in F. novicida-infected wild-type BMDMs (Fig. 4c) . Gbp chr3 -deficient BMDMs, however, displayed normal levels of activation of caspase-1, release of IL-18 and induction of cell death in response to transfected poly(dA:dT) 19 (Fig. 4c) .
Of the GBP-encoding genes located on chromosome 3, IRF1 controlled upregulation of the expression of Gbp2, Gbp3 and Gbp5 (Fig. 4a,b) . Gbp1 was not identified in our microarray data set (Fig. 4a) , consistent with published studies showing that Gbp1 is not expressed in mice on the C57BL/6 background 25 . Given the importance of IRF1 for activation of the AIM2 inflammasome, we set out to identify which of the remaining GBPs was responsible for this activity.
For this, we individually knocked down each of the remaining GBPencoding genes in the chromosome 3 locus (Gbp2, Gbp3, Gbp5 and Gbp7) in primary wild-type BMDMs by an approach involving small interfering RNA and found that silencing of Gbp2 or Gbp5 led to a significant reduction in the activation of caspase-1 and secretion of IL-1β in response to infection with F. novicida ( Supplementary Fig. 3a-c) .
To confirm the role of GBP2 and GBP5 in activation of the AIM2 inflammasome by infection with F. novicida, we stimulated GBP2-deficient (Gbp2 −/− ) and GBP5-deficient (Gbp5 −/− ) BMDMs with F. novicida, poly(dA:dT), LPS plus ATP (to activate the NLRP3 inflammasome) or S. Typhimurium grown to log phase (to activate the NLRC4 inflammasome). Both Gbp2 −/− and Gbp5 −/− BMDMs showed significantly reduced activation of caspase-1, secretion of IL-1β and IL-18 and cell death following infection with F. novicida relative to that in their wild-type counterparts (Fig. 4d-f ), which confirmed a role for both GBP2 and GBP5 in activation of the AIM2 inflammasome. In contrast, stimulation of wild-type, Gbp2 −/− and Gbp5 −/− BMDMs with poly(dA:dT), LPS plus ATP or S. Typhimurium grown to log phase resulted in levels of activation of caspase-1, secretion of IL-1β and IL-18 and cell death similar to those in their wild-type counterparts 19 ( Fig. 4d-f) . These results indicated a non-redundant role for GBP2 and GBP5 in activation of the AIM2 inflammasome in response to infection with F. novicida.
GBPs mediate killing of F. novicida to induce AIM2 activation To investigate whether the expression of GBP2 and GBP5 is entirely under the control of IRF1, we infected wild-type and Irf1 −/− BMDMs with F. novicida and monitored the dynamics of the expression of GBP2 and GBP5 over the course the infection. We found that the expression of GBP2 and GBP5 was delayed compared with the expression of IRF1 in wild-type BMDMs and was reduced in the absence of IRF1 (Fig. 5a) . However, the residual expression of GBP2 and GBP5 in Irf1 −/− BMDMs indicated that an alternative IRF1-independent pathway might exist to induce the expression of these GBPs. It is possible that signaling via type I interferons might trigger an alternative npg pathway that leads to GBP expression independently of IRF1. To investigate this, we infected wild-type and Ifnar1 −/− BMDMs with F. novicida and found that a lack of signaling via type I interferons completely abolished the expression of GBP2 and GBP5 (Fig. 5a ).
Together these findings provided evidence demonstrating that two different members of the GBP family, GBP2 and GBP5, were under the control of IRF1 and signaling via type I interferons and were expressed to specifically engage the AIM2 inflammasome. GBPs can target vacuolar bacteria, such as Salmonella, and induce the recruitment of antimicrobial peptides to kill the bacteria 19, 26 . Whether GBPs mediate killing of cytosolic bacteria such as F. novicida has not been investigated. We therefore used confocal microscopy to observe the spatial distribution of GBP5 relative to that of F. novicida in infected BMDMs. GBP5 was recruited to and engulfed F. novicida bacteria in wild-type BMDMs (Fig. 5b and Supplementary Fig. 4) . The absence of IRF1 led to a significantly reduced prevalence of GBP5-associated bacteria (Fig. 5c) . BMDMs lacking IRF1 or Gbp chr3 also failed to control bacterial replication over time (Fig. 5d) .
To investigate whether GBP5 directly affected the viability of bacteria in macrophages, we infected wild-type and Gbp5 −/− BMDMs with F. novicida expressing green fluorescent protein (GFP) and quantified bacteria in these cells over time. Single-cell analysis revealed that wild-type BMDMs restricted bacterial replication from 4 h to 16 h after infection, whereas Gbp5 −/− BMDMs failed to control bacterial replication at 16 h and harbored a significantly larger number of bacteria than wild-type BMDMs had ( Fig. 5e and Supplementary Fig. 4 ). In addition, GBP5-associated bacteria tended to lose their GFP expression, in contrast to non-GBP5-associated bacteria ( Supplementary  Fig. 4) , which might suggest a loss of bacterial viability following recruitment of GBP5 (ref. 19) . To investigate the hypothesis that IRF1 mediates the AIM2-dependent killing of intracellular bacteria, we infected unprimed wild-type, Irf1 −/− and Aim2 −/− BMDMs with GFPexpressing F. novicida and quantified bacteria in these cells over time.
In agreement with that hypothesis, Irf1 −/− and Aim2 −/− BMDMs failed to suppress bacterial replication over 24 h of infection (Fig. 5f) .
For AIM2 to detect dsDNA, F. novicida or its DNA must be able to escape the vacuole and enter the cytoplasm. Indeed, co-staining of the inflammasome and DNA in F. novicida-infected BMDMs revealed colocalization of DNA with the inflammasome speck ( Supplementary  Fig. 5a ). To investigate whether F. novicida that has escaped from the vacuole engages IRF1-and GBP-dependent activation of the AIM2 inflammasome, we infected wild-type BMDMs with wild-type F. novicida or an isogenic mutant form of F. novicida that fails to disrupt the vacuole as required for escape into the cytoplasm (lacking Expression (log 2 ) 
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A r t i c l e s the gene encoding MglA, which regulates various pathogenicity island proteins, including IglC (F. novicida ∆mglA)) 27 . F. novicida ∆mglA retained the ability to induce IRF1 and the expression of GBP2 and GBP5, although at a lower capacity relative to that of wild-type F. novicida (Supplementary Fig. 5b) . However, F. novicida ∆mglA failed to activate the AIM2 inflammasome to trigger the release of IL-1β and IL-18 and cell death (Supplementary Fig. 5c,d) . The production of other proinflammatory cytokines, tumor-necrosis factor, IL-6 and KC by wild-type BMDMs infected with F. novicida ∆mglA was similar to that of wild-type BMDMs infected with wild-type F. novicida (Supplementary Fig. 5e ), which demonstrated that the inability of F. novicida ∆mglA to activate the AIM2 inflammasome was not due to a general defect in its ability to stimulate cytokines in macrophages. These results suggested that escape from the vacuole into the cytosol was essential for activation of the AIM2 inflammasome and that such escape enhanced but was not indispensable for the induction of IRF1-mediated expression of GBPs. It is possible that additional processes that complement GBP expression are required for full engagement of the AIM2 inflammasome. Indeed, deficiency in IRF1 did not completely abolish the expression of GBP2 and GBP5 (Fig. 5a) , which suggested that IRF1 might direct additional processes other than driving GBP expression to activate the AIM2 inflammasome.
We next investigated whether the absence of IRF1 prevented escape of F. novicida into the cytosol, which might be an additional mechanism that governs the IRF1-dependent activation of the AIM2 inflammasome. Cytosolic pathogens such as F. novicida escape the vacuole and can be used as a mechanism for delivering ligands into the cytosol of a cell 18 . We took advantage of this cytosolic delivery method and infected wild-type, Irf1 −/− and Aim2 −/− BMDMs with F. novicida in the presence of ultrapure LPS from Salmonella to investigate whether Salmonella LPS can be efficiently introduced into the cytosol to activate the inflammasome in the absence of IRF1. We found that wild-type, Irf1 −/− and Aim2 −/− BMDMs all underwent induction of the activation of caspase-1 in response to infection with F. novicida in the presence of Salmonella LPS ( Supplementary Fig. 6a) ; this indicated that the LPS was delivered into the cytosol, which probably activated the non-canonical NLRP3 inflammasome. These findings suggested that in the absence of IRF1, escape into the cytosol was not fully compromised at 20 h after infection.
DNA sensor cGAS mediates activation of the AIM2 inflammasome
Although signaling via type I interferons that engages the AIM2 inflammasome requires IRF1, the pattern-recogntion receptors that induce the production of type I interferons in response to infection with F. novicida have remained largely unexplored. A major pathway that mediates the recognition of cytosolic bacteria for the generation of IFN-β production is the signaling axis of the DNA sensor cyclic GMP-AMP synthase (cGAS) and the adaptor STING 22, 28 . In agreement with that, both cGASdeficient BMDMs and STING-deficient BMDMs (with nonfunctional ('Gt') alleles encoding STING that result in a lack of detectable protein) 28 had impaired ability to robustly activate caspase-1 or induce the release of IL-1β and IL-18 or cell death in response to infection with F. novicida ( Fig. 5g and Supplementary Fig. 6b,c) . In addition, cGAS-deficient BMDMs failed to robustly induce IRF1 expression (Supplementary Fig. 6d) . The residual inflammasome responses in cGAS-deficient and STING-deficient BMDMs infected with F. novicida could have been due to a minor source of type I interferons induced by TLRs, RLRs or other PRRs. Collectively, these findings indicated that the cGAS signaling axis induced type I interferon-dependent expression of IRF1 necessary for the engagement GBP-mediated killing of F. novicida, which ultimately resulted in the release of bacterial DNA for activation of the AIM2 inflammasome (Supplementary Fig. 6e ).
IRF1 provides protection against infection with F. novicida
We extended our findings to an in vivo setting and infected wild-type mice, Irf1 −/− mice, Aim2 −/− mice and mice deficient in both caspase-1 Casp-1 p20 Irf1 −/− , Aim2 −/− and Casp1 −/− Casp11 −/− mice lost more body weight than wild-type mice did, and all succumbed to infection within 6 d, whereas 75% of the wild-type mice survived beyond day 6 (Fig. 6a,b) . Analysis of bacterial burdens showed that Irf1 −/− mice harbored a significantly larger burden of F. novicida in the liver and spleen than did wild-type mice (Fig. 6c) . Similarly, Aim2 −/− mice were significantly more susceptible to infection with F. novicida than were wildtype mice 8, 22 (Fig. 6d) . The greater susceptibility of Irf1 −/− mice than Aim2 −/− mice to infection with F. novicida might suggest that IRF1 is important in multiple antimicrobial defense mechanisms. Analysis of serum IL-18 showed that Irf1 −/− mice had an impaired ability to produce this cytokine following infection with F. novicida; Aim2 −/− and Casp1 −/− Casp11 −/− mice had a similar phenotype for this (Fig. 6e) . Histopathology analysis of liver tissues showed that Irf1 −/− mice failed to control the dissemination of F. novicida (Fig. 6f,g ). In contrast, granulomas that surround infectious particles were present in the liver of wild-type mice (Fig. 6g) . In addition, Irf1 −/− mice had more dead cells than wild-type mice had, but their granulocyte recruitment in the liver was similar to that of wild-type mice, as revealed by TUNEL staining and staining of myeloperoxidase, respectively (Fig. 6h,i) . The greater prevalence of TUNEL staining in Irf1 −/− mice was probably the result of more damage from their greater bacterial burden, which leads to the death of many cell types in the liver. Together these results highlighted a role for IRF1 in the host defense against F. novicida infection via engagement of the AIM2 inflammasome.
DISCUSSION
Various pathways exist for the recognition of DNA for triggering innate immune responses in the cell. TLR9 recognizes CpG dinucleotide DNA in the endosomal compartment to activate the transcription of genes encoding pro-inflammatory cytokines 29 , and STING responds directly to cyclic dinucleotides or serves as an adaptor for a range of DNA sensors to induce type I interferon responses 30 .
AIM2 mediates the sensing of cytosolic dsDNA to initiate assembly of the inflammasome. However, the precise mechanisms by which different pathogens trigger AIM2 have remained unclear 3 . In addition, the function of signaling via type I interferons in activation of the AIM2 inflammasome has remained unclear, given that such signaling is important for mediating activation of the AIM2 inflammasome in response to infection with F. novicida but not in response to infection with MCMV 3 .
Here we have identified an IRF1-dependent pathway downstream of signaling via type I interferons that was responsible for activation of the AIM2 inflammasome by F. novicida. The existence of this 'noncanonical' AIM2 inflammasome pathway defined by its requirement for IRF1, GBPs and signaling via type I interferons is analogous to the non-canonical NLRP3 inflammasome and its requirement for signaling via type I interferons and caspase-11 (refs. 12,13,15,17) . IRF1 was first identified as a virus-induced transcription factor that interacts with regulatory DNA elements of the gene encoding human IFN-β and that contributes to the transcription of the gene encoding IFN-β 31 . Subsequent studies have revealed that both human and mouse IRF1 are involved in the expression of IFN-α, major histocompatibility class I, the GTPase MX (in mice), 2′-5′-oligo A synthetase (in mice) and the regulator ISG54 (in humans) 32 . We have shown here that IRF1 was not absolutely required for the production of IFN-β and certain subtypes of IFN-α in F. novicida-infected macrophages. Instead, we found that cGAS and STING were probably the upstream sensors that initiated the production of type I interferons.
Notably, IRF1 and type I interferons induce GBPs to kill and lyse cytosolic bacteria to drive the release of bacterial DNA for access by AIM2. Although our microarray analysis suggested that IRF1 and IFNAR induced a similar expression profile of interferon-stimulated genes, protein-expression analysis revealed that the expression of GBP2 and GBP5 was completely abolished in the absence of IFNAR1, whereas we observed some residual expression of these proteins in the absence of IRF1. This suggested that IRF1 and IFNAR1 probably each regulated their own set of genes in 
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A r t i c l e s F. novicida-infected macrophages, some of which might be commonly regulated by both IRF1 and IFNAR1. Herpesviruses, including MCMV, enter the host cell via a mechanism that requires binding and fusion of the viral envelope with the host cell membrane, which results in release of the viral capsid into the host cell. Under these circumstances, viral DNA may have access to the cytoplasm directly for detection by AIM2. As shown before 33 , we found that mutant F. novicida that fails to escape the vacuole did not activate the AIM2 inflammasome. In addition, we showed that escape of F. novicida from the vacuole into the cytoplasm enhanced the expression of IRF1 and GBP, which suggested that this process might provide an additional signal for enhancing GBP-mediated killing of the bacteria in the cytosol. F. tularensis live vaccine strain escapes the vacuole as early as 1 h after infection 34 ; this suggests that escape from vacuoles precedes GBP expression, which occurs mostly beyond 16-24 h after infection, following signaling via type I interferons. However, the precise method by which GBPs kill F. novicida is unknown. Published studies have found that GBP1 or GBP7 can recruit additional effector proteins to mediate the killing of pathogens. GBP7 interacts with and recruits p22 phox and other components of the NADPH oxidase to the mycobacteria-containing vacuole to mediate the killing of bacteria, whereas GBP1 facilitates delivery of ubiquitinylated cargo (for example, bacteria decorated with ubiquitin) to autolysosomes to mediate killing 26 . GBP1, GBP2 and GBP5 share a common feature in that they harbor a carboxyterminal 'CaaX' motif (a cysteine residue followed by two aliphatic residues and then any amino acid residue) that is targeted by prenylation, a post-translational modification process that results in the attachment of a lipid hydrophobic moiety to mediate docking of the protein to cellular membranes 35 . It is possible that GBP2 and GBP5 might directly target cytosolic F. novicida to induce recruitment of an antimicrobial process to mediate the killing of this bacteria. Indeed, IRF1 controls the expression of inducible nitric oxide synthase 36 . The contribution of inducible nitric oxide synthase and its connection with GBPs in the activation of the AIM2 inflammasome warrants further investigation.
We observed that macrophages lacking either IRF1 or AIM2 failed to restrict F. novicida replication, whereas mice lacking IRF1 were more susceptible to infection with F. novicida than were mice lacking AIM2. These results suggested that IRF1 controls multiple antimicrobial pathways to suppress the bacterial burden in vivo, which ultimately leads to lysis of the bacterial pathogen for activation of the AIM2 inflammasome. IRF1 has been linked to the production of IL-12. However, published studies have shown that at 3 d after infection with F. tularensis live vaccine strain, mice lacking the IL-12 subunit p40 or p30 or mice treated with antibodies to IL-12 have a bacterial burden similar that of their wild-type or PBS-treated counterparts 37 . In our study, mice lacking IRF1 had a significantly higher bacterial burden than did wild-type mice on day 2, and by day 3, more than 80% of the mice lacking IRF1 succumbed to infection. Thus, we speculate that IL-12 probably does not account for the substantial difference between wild-type mice and Irf1 −/− mice in their bacterial burden.
Additional mechanisms have been identified that control assembly and degradation of the AIM2 inflammasome. Polyubiquitination of ASC recruits the autophage marker p62 to target the AIM2 inflammasome for degradation by autophagy 38 . The human pyrin domaincontaining protein POP3 interacts with the pyrin domain of AIM2 and competes with ASC to inhibit activation of the AIM2 inflammasome in response to poly(dA:dT) and MCMV 39 . The existence of these pathways indicates that controlling activation of the AIM2 inflammasome is important for maintaining homeostasis of the cell.
Indeed, aberrant activation of the AIM2 inflammasome in response to dsDNA could lead to considerable physiological consequences. Increased expression of AIM2 is associated with the development of psoriasis, an abdominal aortic aneurysm and systemic lupus erythematosus, whereas reduced expression of AIM2 is linked to colorectal and prostate cancer 40 . Our findings have identified a previously unknown layer of regulation that governs cytoplasmic sensing of DNA after infection with intracellular pathogens. Therapies that modulate IRF1 activities might lead to enhanced protection against rapid and lethal infection with F. tularensis.
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